Trial intelligence / Profile preview

Autologous PRP for Androgenetic Alopecia

NCT03048461Phase 2Withdrawn

Sponsor
Northwestern University
Start
Jun 2019
Primary completion
Dec 2020
Modality
Adoptive Cell Transfer
01

Overview

A Phase 2 trial of autologous platelet-rich plasma in androgenetic alopecia (AGA), sponsored by Northwestern University. Planned start Jun 2019; status: withdrawn.

02

Drugs

autologous platelet-rich plasma
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT03048461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03048461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call